These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7092732)

  • 1. Two anti-tumour cytotoxic cells in the peritoneal cavity of rats: natural occurrence, augmentation and partial characterization.
    Inoue Y; Nelson DS
    Aust J Exp Biol Med Sci; 1982 Feb; 60(Pt 1):41-53. PubMed ID: 7092732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
    Brunda MJ; Taramelli D; Holden HT; Varesio L
    J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corynebacterium parvum stimulation of adherent and non-adherent cytotoxic cells in mice.
    Hassan ZM; Rees RC; Potter CW
    Br J Cancer; 1981 Oct; 44(4):532-8. PubMed ID: 7295509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further analysis of the anti-tumour effect in vitro of peritoneal exudate cells from mice treated with Corynebacterium parvum.
    Ghaffar A; Cullen RT; Woodruff MA
    Br J Cancer; 1975 Jan; 31(1):15-24. PubMed ID: 1156505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The activation state of macrophage subpopulations from a murine fibrosarcoma.
    Moore K; McBride WH
    Int J Cancer; 1980 Nov; 26(5):609-15. PubMed ID: 6263810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of either rapidly cytolytic macrophages or NK cells in "activated" peritoneal exudates depends on the method of analysis and the target cell type.
    Gray JD; Brooks CG; Baldwin RW
    Immunology; 1981 Apr; 42(4):561-8. PubMed ID: 6263794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced Fc receptor expression by a sub-population of murine intra-tumour macrophages following intravenous Corynebacterium parvum therapy.
    Moore K; McBride WH
    Br J Cancer; 1983 Jun; 47(6):797-802. PubMed ID: 6860547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of natural killer cells induced by Kunjin virus and Corynebacterium parvum with those occurring naturally in nude mice.
    Macfarlan RI; Ceredig R; White DO
    Infect Immun; 1979 Dec; 26(3):832-6. PubMed ID: 160889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro augmentation of rat natural killer (NK) cell activity.
    Reynolds CW; Herberman RB
    J Immunol; 1981 Apr; 126(4):1581-5. PubMed ID: 6451648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corynebacterium parvum-induced resistance to a methylcholanthrene fibrosarcoma.
    Gupta JD; Morahan PS; Kaplan AM
    J Reticuloendothel Soc; 1978 Jan; 23(1):1-9. PubMed ID: 627989
    [No Abstract]   [Full Text] [Related]  

  • 11. Rate of tumour inhibition by activated macrophages in vitro.
    Orinda DA
    East Afr Med J; 1978 Apr; 55(4):177-81. PubMed ID: 679868
    [No Abstract]   [Full Text] [Related]  

  • 12. Quantitative studies of natural immunity to solid tumours in rats. NK activity in animals with primary or transplanted spontaneous tumours.
    Flannery GR; Brooks CG
    Int J Cancer; 1981 Dec; 28(6):747-55. PubMed ID: 7333706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attempts to correlate interferon induction and activation of natural killer cells by Corynebacterium parvum.
    Chmielarczyk W; Kirchner H; Ernst R; Storch E
    Immunobiology; 1985 May; 169(4):403-11. PubMed ID: 2408996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
    Zöller M; Matzku S
    Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Corynebacterium parvum after intraperitoneal injection in hamsters.
    Duthu A; Alexandrov I; Le Goffic N; De Vaux St Cyr C
    Dev Comp Immunol; 1984; 8(1):231-6. PubMed ID: 6233193
    [No Abstract]   [Full Text] [Related]  

  • 16. Augmentation of NK activity by Corynebacterium parvum fractions in vivo and in vitro.
    Lichtenstein A; Bick A; Cantrell J; Zighelboim J
    Int J Immunopharmacol; 1983; 5(2):137-44. PubMed ID: 6874167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo transfer of antitumor activity by peritoneal exudate cells from mice treated with Corynebacterium parvum: reduced effect in irradiated recipients.
    Peters LJ; McBride WH; Mason KA; Hunter N; Basić I; Milas L
    J Natl Cancer Inst; 1977 Sep; 59(3):881-7. PubMed ID: 330869
    [No Abstract]   [Full Text] [Related]  

  • 18. Augmentation of cell-mediated cytotoxicity to a rat lymphoma. II. Characterization of the non-T cytotoxic cells stimulated in vivo by tumour cells as natural killer cells.
    Dawkins HJ; Shellam GR
    Int J Cancer; 1979 Aug; 24(2):244-52. PubMed ID: 314936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage heterogeneity in tumor resistance: cytostatic and cytotoxic activity of Corynebacterium parvum-activated and proteose peptone-elicited rat macrophages against Moloney sarcoma tumor cells.
    Campbell MW; Sholley MM; Miller GA
    Cell Immunol; 1980 Mar; 50(1):153-68. PubMed ID: 7397781
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of gold salts on tumour immunity and its stimulation by Corynebacterium Parvum.
    McBride WH; Tuach S; Marmion BP
    Br J Cancer; 1975 Nov; 32(5):558-67. PubMed ID: 813755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.